FDA Head Stephen Hahn On What's Next For Pfizer Vaccine In Fast-Moving Process
The FDA will likely make a decision about approving Pfizer's vaccine "shortly after" an advisory committee meeting on Thursday. The agency has found "no specific safety concerns" about the vaccine.
The Food and Drug Administration has found that there are "no specific safety concerns" that would stop the agency from approving the COVID-19 vaccine made by Pfizer and BioNTech for emergency use.
Career scientists at the FDA analyzed the data from the ongoing Pfizer trial to form their own conclusions about its safety and efficacy.
Stephen Hahn, who heads the FDA, says the public analysis
